| Kira Shteinberg, | |
|
680 Blair Mill Rd, Horsham, PA 19044-2223 | |
| (267) 965-7962 | |
| Not Available |
| Full Name | Kira Shteinberg |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 680 Blair Mill Rd, Horsham, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073712238 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | SP009452 (Pennsylvania) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | SP009452 (Pennsylvania) | Primary |
| Entity Name | Avellina Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285805507 PECOS PAC ID: 4385715788 Enrollment ID: O20080612000238 |
News Archive
Synapse Biomedical Inc. announced today it has completed the enrollment of the post-approval study of its NeuRx DPS System for ALS patients.
Data from a phase II study of an investigational drug designed to block formation of blood clots show potential for added protection against a second heart attack or stroke among patients who are already taking state-of-the-art prevention therapy.
Your height in adult life significantly affects your quality of life, with short people reporting worse physical and mental health than people of normal height.
Researchers have discovered the mechanism behind one of the Ebola virus' most dangerous attributes: its ability to disarm the adaptive immune system.
Researchers in the University of Georgia's Regenerative Bioscience Center have succeeded in reproducing the effects of traumatic brain injury and stimulating recovery in neuron cells grown in a petri dish.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kira Shteinberg, 680 Blair Mill Rd, Horsham, PA 19044-2223 Ph: (267) 965-7962 | Kira Shteinberg, 680 Blair Mill Rd, Horsham, PA 19044-2223 Ph: (267) 965-7962 |
News Archive
Synapse Biomedical Inc. announced today it has completed the enrollment of the post-approval study of its NeuRx DPS System for ALS patients.
Data from a phase II study of an investigational drug designed to block formation of blood clots show potential for added protection against a second heart attack or stroke among patients who are already taking state-of-the-art prevention therapy.
Your height in adult life significantly affects your quality of life, with short people reporting worse physical and mental health than people of normal height.
Researchers have discovered the mechanism behind one of the Ebola virus' most dangerous attributes: its ability to disarm the adaptive immune system.
Researchers in the University of Georgia's Regenerative Bioscience Center have succeeded in reproducing the effects of traumatic brain injury and stimulating recovery in neuron cells grown in a petri dish.
› Verified 5 days ago